Wordt geladen...
Isocitrate dehydrogenase inhibitors in acute myeloid leukemia
Isocitrate dehydrogenase (IDH) is a key enzyme involved in the conversion of isocitrate to α-ketoglutarate (α-KG) in the tricarboxylic acid (TCA) cycle. IDH mutation produces a neomorphic enzyme, which can lead to the abnormal accumulation of R-2-HG and promotes leukemogenesis. IDH mutation occurs i...
Bewaard in:
| Gepubliceerd in: | Biomark Res |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6806510/ https://ncbi.nlm.nih.gov/pubmed/31660152 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-019-0173-z |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|